Receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 71: Line 71:
*[[Tutorial: The opioid receptor, a molecular switch]]
*[[Tutorial: The opioid receptor, a molecular switch]]
*[[Orexin and Orexin receptor]]
*[[Orexin and Orexin receptor]]
-
The <scene name='77/777976/Cv/4'>suvorexant-binding pocket is open to the extracellular space</scene> through a constricted solvent-accessible channel. A <scene name='77/777976/Cv/5'>complex network of electrostatic interactions includes salt bridges between the protein and the drug, on both sides of the entry channel</scene><ref>PMID:25533960</ref>.
+
The <scene name='77/777976/Cv/4'>Suvorexant (Belsomra) binding pocket is open to the extracellular space</scene> through a constricted solvent-accessible channel. A <scene name='77/777976/Cv/5'>complex network of electrostatic interactions includes salt bridges between the protein and the drug, on both sides of the entry channel</scene><ref>PMID:25533960</ref>.
*[[Belsomra]] and Orexin receptors
*[[Belsomra]] and Orexin receptors
*[[Hypocretin and receptors]]
*[[Hypocretin and receptors]]

Revision as of 12:55, 19 April 2021

Nicotinic Acetylcholine Receptor, PDB code 2bg9

Drag the structure with the mouse to rotate

References

  1. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  2. Krumm BE, White JF, Shah P, Grisshammer R. Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun. 2015 Jul 24;6:7895. doi: 10.1038/ncomms8895. PMID:26205105 doi:http://dx.doi.org/10.1038/ncomms8895
  3. Yin J, Mobarec JC, Kolb P, Rosenbaum DM. Crystal structure of the human OX orexin receptor bound to the insomnia drug suvorexant. Nature. 2014 Dec 22. doi: 10.1038/nature14035. PMID:25533960 doi:http://dx.doi.org/10.1038/nature14035
  4. Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
  5. Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky

Personal tools